Cytosorbents ROE 2010-2025 | CTSO
Current and historical return on equity (ROE) values for Cytosorbents (CTSO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Cytosorbents ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.02B | $0.02B | -107.14% |
| 2024-12-31 | $-0.02B | $0.01B | -133.33% |
| 2024-09-30 | $-0.02B | $0.01B | -105.56% |
| 2024-06-30 | $-0.03B | $0.02B | -133.33% |
| 2024-03-31 | $-0.03B | $0.02B | -131.76% |
| 2023-12-31 | $-0.03B | $0.02B | -122.11% |
| 2023-09-30 | $-0.02B | $0.02B | -85.98% |
| 2023-06-30 | $-0.03B | $0.02B | -81.89% |
| 2023-03-31 | $-0.03B | $0.03B | -82.12% |
| 2022-12-31 | $-0.03B | $0.04B | -74.58% |
| 2022-09-30 | $-0.04B | $0.04B | -80.00% |
| 2022-06-30 | $-0.04B | $0.05B | -59.07% |
| 2022-03-31 | $-0.03B | $0.06B | -44.11% |
| 2021-12-31 | $-0.02B | $0.06B | -33.68% |
| 2021-09-30 | $-0.02B | $0.07B | -21.26% |
| 2021-06-30 | $-0.01B | $0.07B | -14.19% |
| 2021-03-31 | $-0.01B | $0.08B | -13.85% |
| 2020-12-31 | $-0.01B | $0.08B | -15.69% |
| 2020-09-30 | $-0.01B | $0.08B | -34.38% |
| 2020-06-30 | $-0.02B | $0.02B | -123.64% |
| 2020-03-31 | $-0.02B | $0.02B | -167.44% |
| 2019-12-31 | $-0.02B | $0.00B | -216.22% |
| 2019-09-30 | $-0.02B | $0.01B | -164.71% |
| 2019-06-30 | $-0.02B | $0.01B | -106.25% |
| 2019-03-31 | $-0.02B | $0.02B | -102.70% |
| 2018-12-31 | $-0.02B | $0.02B | -93.15% |
| 2018-09-30 | $-0.02B | $0.02B | -90.91% |
| 2018-06-30 | $-0.01B | $0.02B | -101.82% |
| 2018-03-31 | $-0.01B | $0.01B | -97.56% |
| 2017-12-31 | $-0.01B | $0.01B | -144.00% |
| 2017-09-30 | $-0.01B | $0.01B | -275.00% |
| 2017-06-30 | $-0.01B | $0.01B | -550.00% |
| 2017-03-31 | $-0.01B | $0.00B | -1200.00% |
| 2016-12-31 | $-0.01B | $0.00B | -400.00% |
| 2016-09-30 | $-0.01B | $0.00B | -210.53% |
| 2016-06-30 | $-0.01B | $0.00B | -162.96% |
| 2016-03-31 | $-0.01B | $0.01B | -80.00% |
| 2015-12-31 | $-0.01B | $0.01B | -102.56% |
| 2015-09-30 | $-0.02B | $0.01B | -194.29% |
| 2015-06-30 | $-0.02B | $0.01B | -200.00% |
| 2015-03-31 | $-0.02B | $0.01B | -280.00% |
| 2014-12-31 | $-0.02B | $0.00B | -248.28% |
| 2014-09-30 | $-0.01B | $0.01B | -138.46% |
| 2014-06-30 | $-0.01B | $0.01B | -147.37% |
| 2014-03-31 | $-0.01B | $0.01B | -200.00% |
| 2013-12-31 | $-0.01B | $0.00B | -480.00% |
| 2013-09-30 | $-0.01B | $0.00B | -480.00% |
| 2013-06-30 | $-0.01B | $0.00B | -480.00% |
| 2013-03-31 | $-0.01B | $0.00B | -480.00% |
| 2012-12-31 | $-0.01B | $0.00B | -600.00% |
| 2012-09-30 | $-0.01B | $0.00B | -800.00% |
| 2012-06-30 | $-0.01B | $0.00B | -933.33% |
| 2012-03-31 | $-0.01B | $0.00B | -700.00% |
| 2011-12-31 | $-0.01B | $0.00B | -700.00% |
| 2011-09-30 | $-0.01B | $0.00B | -600.00% |
| 2011-06-30 | $-0.01B | $0.00B | -1000.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 1200.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | -1200.00% |
| 2010-03-31 | $0.00B | $0.00B | -600.00% |
| 2009-12-31 | $0.00B | $0.00B | -300.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.066B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |